$LLY Eli Lilly Q3 Earnings
Adj. EPS $7.48, est. $5.59 Rev. $24.40B, est. $22.52B Mounjaro rev. $10.7B, est. $9.95B Zepbound rev. $5.35B, est. $5.01B Foundayo rev. $184M, est. $231.2M Acquired IPR&D charges $4.57/share Sees FY rev. $91B to $92B, saw $85B to $87B Sees FY Adj. EPS $35 to $36, saw $35.50 to $36.50
Adj. EPS $7.48, est. $5.59 Rev. $24.40B, est.
$22.52B Mounjaro rev. $10.7B, est. $9.95B Zepbound rev. $5.35B, est.
$5.01B Foundayo rev. $184M, est. $231.2M Acquired IPR&D charges $4.57/share Sees FY rev. $91B to $92B, saw $85B to $87B Sees FY Adj.
EPS $35 to $36, saw $35.50 to $36.50